During the past decade, Brighton Medical Corporation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Brighton Medical Corporation" are "Acne Scarring of the Face" (1 trials) and "Bilateral Nasolabial Fold Wrinkles" (1 trials). Many other conditions were trialed in "Brighton Medical Corporation" in a lesser frequency.

Most popular intervention types in "Brighton Medical Corporation" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Autologous Human Fibroblasts (azficel-T)" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Brighton Medical Corporation" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Brighton Medical Corporation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Brighton Medical Corporation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Brighton Medical Corporation, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".